Ehlers-Danlos syndrome type IV.

Area of Science:

• Genetics
• Vascular Medicine
• Connective Tissue Disorders

Background:

• Ehlers-Danlos syndrome type IV (EDS IV), also known as vascular EDS, is a severe inherited connective tissue disorder.
• It is characterized by fragile blood vessels, translucent skin, and a predisposition to arterial, digestive, and uterine ruptures.

Purpose of the Study:

• To describe the clinical presentation, diagnosis, and management of Ehlers-Danlos syndrome type IV.
• To highlight the specific complications and genetic basis of EDS IV.

Main Methods:

• Diagnosis relies on clinical signs, non-invasive imaging, and genetic identification of COL3A1 gene mutations.
• Differential diagnoses include coagulation disorders, Silverman's syndrome, Marfan syndrome, and Loeys-Dietz syndrome.

Main Results:

• EDS IV affects 5-10% of EDS cases, with a prevalence of 1/10,000 to 1/25,000.
• Typical vascular complications include arterial dissections and carotid-cavernous fistulae.
• High risk of recurrent colonic perforations and pregnancy-related ruptures.

Conclusions:

• There is no specific cure for EDS IV; management focuses on symptomatic treatment and prophylaxis.
• Vascular, digestive, or uterine emergencies necessitate immediate hospitalization and intensive care.
• A conservative approach is generally recommended for vascular complications, with surgery reserved for urgent, life-threatening situations.